BMEZ Plans Tender Offer After 11.05% Average Discount
View the BMEZ Dividend Stock Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) said on October 1, 2026, that it will conduct a tender offer after its shares traded at an average 11.05% discount to net asset value during the nine months ended September 30.
BMEZ plans to offer to repurchase up to 5% of its outstanding common shares at 98% of NAV. The offer is expected to begin October 16 and expire at 5:00 p.m. Eastern time on November 18, unless extended. The purchase price will use NAV calculated on the next NAV-calculation day after expiration.
If shareholders tender more than 5% of outstanding shares, BMEZ will accept shares on a pro rata basis. That means an investor may have only part of a tender accepted. BlackRock expects payment for accepted shares within about five business days after expiration.
The offer can give participating shareholders liquidity near NAV and may reduce the fund’s share count. For continuing shareholders, the result will depend on participation, the final NAV-based purchase price, transaction costs, and how the market discount behaves after completion. BlackRock cautioned that the program may not narrow the discount.
The tender offer does not create portfolio earnings or directly improve distribution coverage. It is a capital-management response to the trading discount. The next evidence to watch is the formal Schedule TO, final terms, participation level, and post-offer NAV and discount.
Sources
This article is general information, not personalized investment advice. Fly High Investing may hold securities discussed in this article.